LANGUAGE:
LANGUAGE:
Our people are our pride, helping companies resonate with their customers for 20+ years.
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Solutions
Our experts know the in-and-outs of your industry & its challenges.
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Our people are our pride, helping companies resonate with their customers for 20+ years.
About Us
Key Facts
Leadership
Insights
News
Trust Center
We create, transform, test, and train more content than anyone in the world – from text, voice, audio, video, to structured & unstructured data.
Content Services
Technical Writing
Training & eLearning
Financial Reports
Multicultural Marketing
Digital Experience Assessments
Translation Services
Translation
Video Localization
Software Localization
Website Localization
Translation for Regulated Companies
Interpretation
Multilingual SEO & Digital Marketing
Content Optimization
Testing Services
Functional QA & Testing
Compatibility Testing
Interoperability Testing
Performance Testing
Accessibility Testing
UX/CX Testing
Solutions
Digital Marketing
Live Events
Machine Translation
Our Knowledge Hubs
Positive Patient Outcomes
Future of Localization
Innovation to Immunity
COVID-19 Resource Center
Disruption Series
Patient Engagement
Lionbridge Insights
Our experts know the in-and-outs of your industry & its challenges.
Life Sciences
Banking & Finance
Retail
E-Commerce
Games
Automotive
Consumer Packaged Goods
Technology
Industrial Manufacturing
Legal Services
Travel & Hospitality
Harness the Lionbridge Lainguage Cloud to support your end-to-end localization and content lifecycle
Lainguage Cloud™ Platform
Connectivity
Translation Community
Workflow Technology
Smairt Content™
Smairt MT™
Smairt Data™
Language Quality
Analytics
SELECT LANGUAGE:
In 2017, two new European Regulations published on EUR-Lex turned the world upside down for medical device manufacturers wanting to place their medical devices in the European market. The MDR and the IVDR replace old medical device directives that date back to the 1990s. As of the Date of Application of the IVDR on 26 May 2022, the transition period is now complete for both of these new Regulations. These Regulations are now in full effect, although a few devices have exceptions and may stay on the market for a further "grace period”.
26 May 2022 also marks the first anniversary of the Date of Application of the MDR. During the past year, Lionbridge has been partnering with our MedTech clients to find suitable and flexible solutions to the language challenges emerging from the regulatory requirements under these new reforms. The journey has just begun, and we are committed to helping clients centralize translations and leverage language assets throughout the device life cycle.
Both Regulations enforce life cycle-long controls over manufacturers’ device portfolio and public disclosure of performance and safety of devices via the EUDAMED database. There has never been a better time for MedTech manufacturers to take a solid look at the language strategy across the device portfolio.
The MDR and IVDR present similar burdens of content and language challenges for manufacturers. This workload is due to the increase in new documentation requirements during the device life cycle for both device types as well as new transparency requirements for medical technologies placed on the EU market.
Lionbridge has continuously presented our views and recommendations on how manufacturers can tackle language barriers with our MDR series. We have expanded our insights to include the IVDR with the publication of our new IVDR white paper.
One recommendation we continue to offer is that manufacturers should plan translations and language assets along with other device development and design control activities.
The EU is a multilingual region. Despite harmonization being a major incentive for upgrading the old EU Directives to Regulations, language remains a national matter that is determined by each National Competent Authority. We encourage manufacturers to assess language as a layered activity in order to help control and optimize language activities across your device portfolios.